Stem cells injected into hands aim to heal stubborn scleroderma ulcers

NCT ID NCT03211793

Recruiting now Disease control Sponsor: UMC Utrecht Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-phase trial tests whether injecting stem cells (mesenchymal stromal cells) into the hand and forearm muscles can safely help heal painful finger ulcers in people with scleroderma. The study includes 20 participants whose ulcers have not improved with standard treatments. The main goal is to check for side effects, but researchers will also look for signs of better blood flow and ulcer healing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mesenchymal stromal cells (stem cells)
What this could lead to: If it works, this could offer a new way to heal stubborn finger ulcers in people with scleroderma, reducing pain and preventing tissue loss.
What could go wrong: This is a very early, small trial (20 people) focused on safety first. It may not show clear benefit, and there are risks like injection-site reactions or worsening ulcers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIGITAL ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse scleroderma digital ulcers systemic sclerosis vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIGITAL ULCER SYSTEMIC SCLEROSIS

Contacts and locations

Locations

Universitair Medisch Centrum Utrecht
RECRUITING

Utrecht, 3584 CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.